Assessing the Prognostic Value of PAX2 and PTEN in Endometrial Carcinogenesis

Endocrine-Related Cancer - United Kingdom
doi 10.1530/erc-18-0106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Assessing the Incremental Value of Diagnostic and Prognostic Markers: A Review and Illustration

European Journal of Clinical Investigation
MedicineBiochemistryClinical Biochemistry
2011English

Steroid Hormone Intervenes in the Endometrial Tumorigenesis of Pten Ablation

Journal of Cancer Prevention
2013English

PTEN Expression in Benign Human Endometrial Tissue and Cancer in Relation to Endometrial Cancer Risk Factors

Cancer Causes and Control
Cancer ResearchOncology
2015English

Differential Expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 During Uterine Cervix Carcinogenesis: Diagnostic and Prognostic Value

British Journal of Cancer
Cancer ResearchOncology
2010English

LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer

Frontiers in Oncology
Cancer ResearchOncology
2016English

EP18.09: The Value of Diagnosing Endometrial Lesions Regarding Endometrial Cancer

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2018English

Prognostic Significance of miR-205 in Endometrial Cancer

PLoS ONE
Multidisciplinary
2012English

Prognostic Value of Microcirculatory Changes and Alterations in the Cellular Microenvironment in Patients With Glandular Hyperplasia of the Endometrium and Endometrial Cancer (Literature Review)

Tumors of female reproductive system
2019English

PTEN Loss Predicts Response to Notch Pathway Inhibition in Endometrial Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy